Cargando…
Bulking agents for urinary incontinence: what, when and where?
Autores principales: | Kasyan, George, Pushkar, Dmitry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643717/ https://www.ncbi.nlm.nih.gov/pubmed/26568878 http://dx.doi.org/10.5173/ceju.2015.e106 |
Ejemplares similares
-
Collagen type 3A1 and 1A1 polymorphisms in women with pelvic organ prolapse and urinary incontinence assessed with Sanger sequencing method
por: Kasyan, George, et al.
Publicado: (2021) -
Analysis of 1,000 cases of synthetic midurethral slings used for treatment of female urinary incontinence – a single-center experience
por: Pushkar, Dmitri, et al.
Publicado: (2011) -
Stress urinary incontinence: What, when, why, and then what?
por: Magon, Navneet, et al.
Publicado: (2011) -
Particulate Versus Non-Particulate Bulking Agents In The Treatment Of Stress Urinary Incontinence
por: Chapple, Christopher, et al.
Publicado: (2019) -
Tadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in Russia
por: Govorov, Alexander, et al.
Publicado: (2014)